NEW YORK (GenomeWeb) – Bruker reported after the close of the market Wednesday that its first quarter revenues fell around 17 percent, largely due to divestitures, the negative effect of currency translation, and weak sales for its nuclear magnetic resonance business.

Bruker reported total revenues of $353.5 million for the three months ended March 31, down from $423.7 million for the first quarter of 2014 and below analysts' consensus estimate of $369.8 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.